AI assistant
Sending…
RESMED INC — Director's Dealing 2010
May 5, 2010
30071_dirs_2010-05-05_274474c1-aa4a-4a95-a5ee-fe0668c66c3c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2010-05-03
Reporting Person: QUINN MICHAEL A (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2010-05-03 | ResMed Common Stock | M | 32000 | $26.10 | Acquired | 203000 | Direct |
| 2010-05-03 | ResMed Common Stock | S | 32000 | $68.50 | Disposed | 171000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2010-05-03 | ResMed Common Stock Options | $26.10 | M | 32000 | Disposed | 2010-07-07 | ResMed Common Stock (32000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| ResMed Common Stock | 3300 | Indirect |
Footnotes
F1: Represents first day options became exercisable.
F2: We previously reported an aggregated amount of derivative securities beneficially owned. We are now reporting only those derivative securities beneficially owned that are of the same class as those disposed of in this trade -- identified by the SEC to be those that have the same grant date and exercise price.
More from RESMED INC
Regulatory Filings
2026
May 26
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 10
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 3
Interim / Quarterly Report
2026
Jan 30
Regulatory Filings
2026
Jan 29